Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
NCT05800600Phase 2Recruiting
- Sponsor
- Fox Chase Cancer Center
- Start
- Mar 2023
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iron sucrose in anemia, sponsored by Fox Chase Cancer Center. Primary endpoint: Mean change from baseline to highest Hgb value at 6 weeks. Started Mar 2023; status: recruiting.
02
Drugs
iron sucrose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05800600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800600.